Search
for
Sort by
Research 31–60 of 376
- Sorafenib-induced Facial Acneiform Eruption
- Proceedings of the Heinz Maurer-Symposium “Review and Preview in Science for Healthy Skin” June 28th 2014, Jakobsberg, Boppard, Germany
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- Oncogenic senescence: a multi-functional perspective
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- The PDGF/PDGFR pathway as a drug target
- Protein-phosphatase inhibitors block root hair growth and alter cortical cell shape of Arabidopsis roots
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Preparation, Characterization and Molecular Docking Study of some New Pyrazole Derivatives Derived from 2-Mercaptobenzothiazole.
- Abstracts
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Wedelolactone Attenuates Pulmonary Fibrosis Partly Through Activating AMPK and Regulating Raf-MAPKs Signaling Pathway
- Continuous MEK inhibition by AZD6244 (ARRY-142886) results in exhaustion of the cutaneous keratinocytic stem cell pool and resembles senescence driven skin aging
- 645 MIG6 is MEK-regulated and affects EGF-induced migration in mutant NRAS melanoma
- Molecular Genetics of the PI3K-AKT-mTOR Pathway in Genodermatoses: Diagnostic Implications and Treatment Opportunities
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Sorafenib-Associated Facial Acneiform Eruption
- Diseases of the Canine Prostate Gland
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Mathematical Modeling and Inference of Epidermal Growth Factor-Induced Mitogen-Activated Protein Kinase Cell Signaling Pathways
- Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands